Toronto Dominion Bank’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

Toronto Dominion Bank’s Portfolio FLAC Stock Details FLAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-136,185	Closed	-$1.36M	–	1674
2022 Q3	$1.36M	Hold	136,185	–	–	﹤0.01%	1003
2022 Q2	$1.34M	Hold	136,185	–	–	﹤0.01%	827
2022 Q1	$1.34M	Hold	136,185	–	–	﹤0.01%	865
2021 Q4	$1.33M	Buy	136,185 +72,702	+115%	+$712K	﹤0.01%	951
2021 Q3	$624K	Buy	63,483 +2,050	+3%	+$20K	﹤0.01%	963
2021 Q2	$600K	Buy	61,433 +26,905	+78%	+$265K	﹤0.01%	952
2021 Q1	$344K	Buy	+34,528	New	+$352K	﹤0.01%	1038

Toronto Dominion Bank's FLAC Position: Q4 2022 in Review

Toronto Dominion Bank sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q4 2022, closing a stake of 136,185 shares — an estimated $1.36M sold.

Toronto Dominion Bank first reported a position in FLAC in Q1 2021 and held it in 7 quarters. The position peaked at $1.36M in Q3 2022. 0 funds tracked by Wall St. Rank hold FLAC as of Q4 2022.

Toronto Dominion Bank reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
Toronto Dominion Bank sold 136,185 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q4 2022, an estimated $1.36M.
Toronto Dominion Bank first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q1 2021 and held it in 7 quarters.
Toronto Dominion Bank's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $1.36M in Q3 2022.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q4 2022.

Based on Toronto Dominion Bank's 13F filing for Q4 2022, filed 7 Feb 2023.